Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

Example Input: Paragraph: WPRI-TV reports that a review of state Department of Health records found at least 450 health violations. The number is likely larger because 56 schools were marked for re-inspection, and some have been inspected multiple times. “Schools are really important because we have a lot of little kids,” said Cathy Feeney, chief of the agency’s retail food service program. “If one thing goes wrong, a lot of people can get sick.”   Rodent droppings were found at the middle school and at an elementary school in East Greenwich. Records show inspectors returned to both schools several times in October and November. Victor Mercurio, the East Greenwich superintendent, said the district is working with a pest control company. Schools in communities including Barrington, Pawtucket, Providence, and Woonsocket have also been flagged for pest problems. Inspectors have also found other issues including debris on surfaces, dumpsters in the wrong place and appliances in poor repair. Several schools were forced to throw out food because it was not stored at the proper temperature. None of the violations discovered in any of the schools have resulted in the closure of a cafeteria. Claim: Multiple health code violations found at school cafeterias.
Example Output: Public health officials have found hundreds of health code violations in cafeterias at schools across Rhode Island.

Example Input: Paragraph: Dr. Chris Baumert, a family physician at RiverStone Health, told the Billings Gazette there’s been a steep increase in the number of cases of syphilis, gonorrhea and chlamydia. The U.S. Centers for Disease Control and Prevention has labeled the threat of antibiotic-resistant gonorrhea one of the nation’s most urgent public health threats. The rate of gonorrhea cases in the United States has increased 75.2 percent since the historic low in 2009. Montana officials are projecting more than 1,000 cases of gonorrhea in the state this year, compared to 867 in 2017. ___ Information from: The Billings Gazette, http://www.billingsgazette.com Claim: STD cases increase in Montana.
Example Output: Health officials say cases of sexually transmitted diseases have increased in Montana.

Example Input: Paragraph: They said the Takeda Pharmaceutical Co Ltddrug Actos, known  generically as pioglitazone, is the first diabetes therapy  shown to reduce the progression of atherosclerosis. “The results are very striking. In my view, this is really  a breakthrough study,” Dr. Steven Nissen of the Cleveland  Clinic, who led the study, said in an interview. “No one has ever shown any diabetes therapy could slow the  progression of disease. Keep in mind the leading cause of death  for diabetics is cardiovascular disease,” said Nissen, whose  findings were published online in the Journal of the American  Medical Association and presented at a meeting of the American  College of Cardiology in Chicago. Diabetics are especially prone to atherosclerosis, which  involves the build-up of fat, calcium and other deposits in the  arteries. The study, known as PERISCOPE, compared two types of  medications to treat type 2 diabetes — Actos and glimepiride,  an older sulfonylurea drug that is among the most commonly used  classes of diabetes therapies. Actos is in a class of drugs known as thiazolidinediones, a  relatively new group of antidiabetic agents that are known to  raise the risk of heart failure and bone fractures. In the current study, Nissen and colleagues compared the  two drugs to see how well they reduced progression of  atherosclerosis in 543 patients with type 2 diabetes and  coronary disease. The trial took place from 2003-2006 in 97 hospitals in  North and South America. The team used intravascular ultrasound  to measure fatty deposits inside the arteries. Patients took glimepiride or pioglitazone for 18 months and  their arteries were measured again for plaque build-up. While plaque increased 0.73 percent in the glimepiride  group, it fell 0.16 percent in the pioglitazone group. The researchers also looked at maximum plaque thickness and  saw it increased in the glimepiride group and decreased in the  pioglitazone group. “Evidence for a slowing of disease progression has proven a  very challenging end point in recent years with the prominent  failure of several promising approaches,” Nissen and colleagues  wrote in JAMA. Nissen said a single study is not enough to change medical  practice, but it does signal the need for more research on how  different diabetes drugs stack up. Dr. Salim Yusuf of McMaster University in Ontario, Canada,  however, noted that patients in the study who took Actos did  have a significant number of fractures. “We need proper studies in diabetes. This suggests there  may be differences in drugs. We need to test that,” Yusuf told  reporters. Claim: Actos arrests heart disease in diabetics: study.
Example Output:
The popular diabetes pill Actos  prevented the build-up of fatty deposits in heart arteries in a  study of patients with type 2 diabetes, U.S. researchers said  on Monday.